67457-0991 OGIVRI - CanMED: NDC

Product NDC:

67457-0991

Brand Name:

OGIVRI

Generic Name:

Trastuzumab

Dosage Form Name:

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Administration Route:

Intravenous

Substances:

Name: TRASTUZUMAB

Strength: 150.0

Unit: mg/7.4mL

Packages:

Code: 67457-0991-15

Description: 1 VIAL in 1 CARTON (67457-991-15) / 15 mL in 1 VIAL

Effective Date: Nov. 29, 2019

Discontinued: Feb. 28, 2027

SEER*Rx Category:

Immunotherapy

Major Class:

Monoclonal Antibody

Minor Class:

HER2

Orphan Drug Designation:

Status:

In Use

CanMED and the Oncology Toolbox